<- Go Home
Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally.
Market Cap
$10.3B
Volume
514.2K
Cash and Equivalents
$179.2M
EBITDA
$959.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$1.5B
Profit Margin
35.98%
52 Week High
$275.00
52 Week Low
$161.65
Dividend
N/A
Price / Book Value
2.75
Price / Earnings
23.78
Price / Tangible Book Value
-65.25
Enterprise Value
$13.0B
Enterprise Value / EBITDA
11.15
Operating Income
$628.1M
Return on Equity
12.60%
Return on Assets
4.99
Cash and Short Term Investments
$179.2M
Debt
$2.8B
Equity
$3.8B
Revenue
$4.1B
Unlevered FCF
$460.8M
Sector
Life Sciences Tools and Services
Category
N/A